Abstract We studied the effects of an organic nitric oxide (NO) donor SPM-5185 in a rat carotid artery intimal injury model. Seven days after injury, the two end segments of the injured carotid arteries were studied for endothelial release of NO, and the middle segments were used for histological measurement of the intimal-to-medial (I/M) ratio and scanning electron microscopy of the luminal surface. The NO donor , representing an ---82% inhibition of intimal thickening. SPM-5185 infusion resulted in accelerated regeneration of endothelial cells on the intimal surface at 7 days. SPM-5185 also markedly retarded the proliferation of cultured rat vascular smooth muscle cells at 7 days compared with SPM-5267 (P<.01). We conclude that a constant intravenous infusion of a subvasodilator dose of NO donor SPM-5185 significantly accelerates the functional recovery of the regenerating endothelium and also inhibits vascular smooth muscle cell proliferation, which contributes to myointimal thickening. (Circ Res. 1994;75:77-84.) Key Words * nitric oxide donor * endothelial regeneration * smooth muscle cell proliferation * endothelium-derived relaxing factor * scanning electron microscopy sponse of the vascular wall in response to endothelial injury or denudation may result partially from reduced production or release of NO by the regenerating endothelial cells.13'4 The purposes of the present study were to (1) study the endothelial morphological and functional changes, including both vasodilator-stimulated and basal NO release, after 1 week of intimal injury, (2) investigate the role of a new organic NO donor, SPM-5185, at a dose below the threshold for vasodilation, in inhibiting myointimal thickening and preserving endothelial function in injured rat carotid arteries,15 and (3) determine the effects of SPM-5185 in cultured rat vascular smooth muscle cells as a potential mechanism for protection against neointimal proliferation.
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Materials and Methods

Experimental Procedures
The present study was carried out according to the "Guide for the Care and Use of Laboratory Animals" as adopted and promulgated by the National Institutes of Health.
Adult male Sprague-Dawley rats weighing 275 to 300 g were anesthetized intraperitoneally with sodium pentobarbital (50 mg/kg). After a longitudinal neck incision, a 1.5-cm-long segment of the left carotid artery was carefully isolated by using the first and the eighth tracheal cartilage as the respective proximal and distal borders of the isolated vascular segment. Two 4-0 silk ligatures were tied in a slipknot around the proximal and distal ends of the artery. After the blood inside the vessel segment was aspirated with a 30-gauge needle placed in the proximal end of the artery, a stream of nitrogen gas was allowed to flow through the lumen for 1 minute at a flow rate of 2 mL/min. This procedure does not cause a visible distension of the vessel wall but results in deendothelialization with slight injury to the underlying media. Thereafter, the ligatures were removed, and a direct gentle pressure was applied to the puncture site for several minutes. Once hemostasis was achieved, reestablishment of blood flow in the carotid artery was confirmed. Subsequently, miniosmotic infusion pumps (model 2ML1, Alza Corp) were implanted subcutaneously in the neck and connected to the external jugular vein on the contralateral side to the injured carotid artery via a subcutaneously tunneled PE-60 catheter. These pumps are designed to deliver 10 ,uL/h of fluid for up to 7 days. Rats were randomly assigned to one of the following four experimental groups: (1) six sham-injured rats, (2) six injured rats given vehicle (0.9% NaCI at 240 ,uL/d), (3) eight injured rats given (30 ,.g/d) , and (4) seven injured rats given SPM-5267 (30 gg/d). SPM-5185 or SPM-5267, diluted in 0.9% NaCI, or saline alone was intravenously infused continuously for 7 days. This infusion rate (ie, 1.25 ,ug/h) did not significantly alter mean arterial blood pressure over a 3-hour infusion period in three rats. Mean arterial blood pressure was 139± 7 mm Hg initially and 138+9 mm Hg after 3 hours of SPM-5185 infusion (P=NS). All incisions were aseptically closed, and after recovery from the anesthetic, the rats were returned to the anitnal facility. After 7 days, the rats were reanesthetized, and the injured carotid arterial segments were removed, with the first and the eighth tracheal cartilage used as markers. The isolated arteries were carefully cleaned of connective tissue and cut into three segments. Segments from the proximal and distal ends were used for physiological assessment of endothelial function in carotid arterial rings, and the middle segment was used for histological and scanning electron microscopy studies. At the end of the experiments, the pumps were reinoved, and the volume of the remaining pump fluid was measured to determine the delivered drug volume. Rats developing a clot or a blocked catheter after 7 days were excluded from the studies. These included one rat given vehicle, one rat given SPM-5267, and two rats given SPM-5185. As an additional control, a solution of SPM-5185 was maintained in a water bath at 37fC for 7 days, after which it was added to isolated rat carotid rings. At 50 ,umol/L, the SPM-5185 incubated for 7 days relaxed isolated rat carotid arterial rings 64±5% (n=4) compared with fresh SPM-5185 76±5% (n=4) carotid arterial rings (P=NS). Five additional rats subjected to air injury were infused with recombinant human superoxide dismutase (hSOD) at a rate of 1 mg/d for 7
days. This corresponded to 5 ,gg/mL hSOD, which was sufficient to inhibit 80% of the superoxide radicals formed by xanthine-xanthine oxidase.
Isolated Carotid Ring Studies
The two end segments of injured carotid arteries were cut into vascular rings 2 to 3 mm in length and placed in 10-mL chambers filled with Krebs-Henseleit (K-H) solution consisting of (mmol/L) NaCI 118, KCl 4.75, CaCI2 . 2H20 2.54, KH2PO4 1.19, MgSO4 . 7H20 1.19, NaHCO3 12.5, and glucose 10.0. The rings were then mounted on stainless-steel hooks, suspended in 10-mL tissue baths, and subsequently connected to FT-03 force displacement transducers (Grass Instrument Co) to record changes in force with a Grass model 7 oscillographic recorder. The baths were filled with 10 mL K-H buffer and aerated at 37°C with a gas mixture of 95% 02/5% CO2.
Carotid arterial rings were stretched to a preload of 0.5 g of force and equilibrated for 60 to 90 minutes. During this period, the K-H solution in the tissue baths was replaced with fresh K-H solution every 15 to 20 minutes. After equilibration, the rings were then exposed to 10 nmol/L U46619 (9,11-ep- oxymethanoprostaglandin H2, Biomol Laboratories), a thromboxane A2 mimetic that generates '0.3 to 0.4 g of developed force. After a stable contraction was obtained, 0.1, 1, 10, 100, 1000, and 10 000 nmol/L acetylcholine (ACh), an endothelium-dependent receptor-mediated vasodilator, was added to the bath to assess regenerated endothelial function after injury. Once maximal vasodilation occurred, the rings were washed, and developed force was allowed to return to baseline. The procedure was repeated with A23187, an endothelium-dependent non-receptor-mediated vasodilator (1, 10, 100, and 1000 nmol/L). These concentrations of ACh and A23187 failed to relax carotid arterial rings mechanically denuded of endothelium. These rings were washed and allowed to equilibrate to baseline again. The procedure was once again repeated with acidified NaNO2, an endothelium-independent vasodilator (1, 10, and 100 .mol/L) to assess the ability of smooth muscle to relax in response to endothelium-independent vasodilator. To study endothelial basal NO release, after a stable contraction to U46619 was obtained, 1 mmol/L NG-nitro-L-arginine methyl ester (L-NAME) (Calbiochem) was added, and basal NO release was assessed by measuring L-NAME-induced vasocontraction. The L-NAME-induced contraction could be reversed by 1 mmol/L L-arginine but not by 1 mmol/L D-arginine, indicating that L-NAME specifically blocked NO synthesis in these vessels.
Histological Analysis
To confirm the degree of reendothelialization of the luminal surface and to evaluate the morphology of the regenerated endothelial cells 7 days after injury, the carotid arterial rings were collected at the end of the physiological studies for assessment of endothelial surface area of the rings. The technique was modified from that reported by Poole et a116 for staining intercellular junctions. Vessel rings from each group were bathed in 5% glucose for 3 minutes and stained with 0.25% silver nitrate, followed by fixation for 10 minutes in 0.9% NaCl and rinsing with 5% glucose several times. Each vessel was opened longitudinally and mounted flat on glass slides for subsequent light microscopy.
To measure the intimal-to-medial (I/M) ratio, the middle segments of injured carotid arteries isolated from five or six rats in each of the four different groups were also collected and fixed in 2.5% glutaraldehyde. After fixation, the vascular segments were dehydrated in graded ethanol and xylene and embedded in paraffin. Four-micron-thick sections were cut, mounted on glass slides, and stained with hematoxylin and 1% alcoholic eosin. The slides were projected at x400 magnification with a Nikon 591027 light microscope connected to a high-resolution television monitor (PVM-122, Sony), and the intimal and the medial areas were then calculated. The internal elastic lamina was divided by the area of the media between the internal and external elastic lamina to obtain the I/M ratio. The I/M ratio was used as an index of total intimal thickening or intimal smooth muscle cell proliferation. Specimens that were distorted or torn were excluded.
To evaluate the early effects of injury, 12 additional rats were killed immediately after the injury or 24 hours later.
Specimens from each injured carotid arterial segment were stained with silver and hematoxylin-eosin for light microscopy by using the same procedure as described above.
Scanning Electron Microscopy
An additional three rats per group were used for scanning electron microscopy. Specimens were fixed overnight at 40C in 2.5% glutaraldehyde in 0.13 mol/L cacodylate buffer, pH 7.4. After rinsing twice in buffer, specimens were postfixed in 1% osmium tetroxide at 40C for 1.5 hours, rinsed three tirnes in cacodylate buffer, and dehydrated through graded concentrations of ethanol. The specimens were critical point-dried from 100% ethanol with liquid CO2. After drying, the specimens were bisected to expose the luminal surface, mounted on stubs, and sputter-coated with gold. The specimens were viewed and photographed at 25 kV in a JEOL 35-C scanning electron microscope. Photomicrographs were taken at x1000 magnification. Smooth muscle cells were isolated and cultured from the thoracic aorta of rats. The aorta was isolated, the tunica adventitia was removed, and the lumen was denuded of endothelium. The resulting tissue was cut into 2-mm2 cubes, placed on gelatin-coated flasks, and allowed to adhere in the presence of media. The cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Hyclone), 100 U/mL penicillin, 100 jug/mL streptomycin, and 0.25 gg/mL amphotericin B. Cells were subcultured, and the purity of the cultures was determined by a-actin immunofluorescence. The purity of the rat aortic smooth muscle cells was >97%. Unless otherwise noted, all reagents were obtained from GIBCO BRL.
Assay of Cell Proliferation
Cultures from the third to fifth passages were established on 24- Also, there are numerous adhered platelets to the injured surface. This pattern of injury remains essentially unchanged at 3, 5, and 7 days in untreated vessels.
The only change of note is a decline in adhered platelets at 5 and 7 days. However, treatment with SPM-5185 for 7 days resulted in a significant reendothelialization (Fig  2) , which did not occur after treatment with the non-NO-donating compound SPM-5267. The reendothelialization is marked but is not complete as compared with the control uninjured segment. Thus, SPM-5185 appears to promote reendothelialization of the artery at 7 days.
The normal control rat carotid arterial intima consists of only a monolayer of endothelial cells (Fig 3) . One day after injury, a marked endothelial denudation occurred, as shown in Figs 1 and 3 . At 7 days after injury, a marked intimal proliferation developed. SPM-5267, a non-NOdonating compound did not alter these changes (Fig 3) .
However, rats treated with SPM-5185 (30 gg/d), a substance with an NO moiety, exhibited significantly attenuated intimal thickening at 7 days (Fig 3) .
Morphometric analysis of carotid arteries isolated from injured rats given vehicle or SPM-5267 showed an average I/M ratio of 0.78±0.03, and 0.74±0.05, respectively (Fig 4) . These values are significantly elevated above control values (P<.001). However, carotid arteries isolated from injured rats given SPM-5185 (30 gg/d) exhibited a markedly reduced I/M ratio of 0.13±0.03 (P<.01) (Fig 4) the case for the inactive nitrate, SPM-5267, which lacks the NO moiety. Infusion of SPM-5267 resulted in an L-NAME-induced vasocontraction of only 43±17 mg 7 days after artery injury (P=NS from vehicle). Since the vasocontractions induced by 10 nmol/L U46619 and 40 mmol/L KCl were not significantly different among the groups 7 days after injury, the reduced L-NAMEinduced vasocontraction in the vehicle-treated and SPM-5267-treated groups is not the result of vascular smooth muscle injury. Therefore, it is very likely that it is the NO moiety in the SPM-5185 that preserves basal NO release after intimal injury. This is consistent with the effects of SPM-5185 observed via scanning electron microscopy.
NO release can be augmented by stimulation with endothelium-dependent vasodilators, including ACh. Intimal injury impaired the carotid artery rings from relaxing fully to ACh but not to NaNO2, indicating a marked endothelial dysfunction without impairment of vascular smooth muscle responsiveness. Fig 6 summa rizes the vasorelaxant responses of isolated carotid arterial rings to ACh. Seven days after injury, carotid arterial rings isolated from sham-injured rats relaxed 90±2% to ACh. In contrast, carotid arterial rings isolated from injured rats given either vehicle or SPM-5267 relaxed only 17+5% and 15 ±5%, respectively. These data indicate a significant reduction of endothelium-dependent receptor-mediated vasorelaxation in carotid arteries observed from injured rats given either 0.9% NaCI or SPM-5267. However, those carotid arterial rings isolated from injured rats given SPM-5185 showed significantly improved vasorelaxation responses to ACh (67±6%, P<.01 compared with vehicle-treated and SPM-5267-treated groups). Carotid rings isolated from injured rats infused with hSOD over 7 days did not significantly relax to ACh (22±6%, P= NS from vehicle). Fig 7 summarizes the vasorelaxant responses of isolated carotid arterial rings to the endothelium-dependent non-receptor-mediated vasodilator A23187. Seven days after injury, carotid arterial rings isolated from sham-injured rats relaxed 80±3% to 1 gmol/L A23187. In contrast, carotid arterial rings isolated from injured rats given either vehicle or SPM-5267 relaxed only minimally to 1 umol/L A23187. These data indicate a significant reduction of endothelium-dependent nonreceptor-mediated vasorelaxation in the carotid arteries of injured rats given vehicle or SPM-5267. However, carotid arterial rings isolated from injured rats given SPM-5185 showed significantly improved vasorelaxation responses to 1 gmol/L A23187 (P<.01) compared with vehicle-treated and SPM-5267-treated groups. Therefore, 7 days after injury, there was a significant and selective attenuation of the vasorelaxant response to both endothelium-dependent vasodilators in the carotid arteries of injured rats not given an NO donor. This decreased vasorelaxation to endothelium-dependent vasodilators was not due to a muscarinic receptor defect, since a reduced vasorelaxant response was also obtained to A23187. Carotid rings isolated from injured rats infused with hSOD did not relax to A23187 significantly above vehicle-treated rings (24±7%, P=NS from vehicle). major consequence of the NO-induced protective effect in carotid arterial injury appears to be due to inhibition of vascular smooth muscle cell proliferation. Discussion Our present study demonstrates that a brief period of desiccation of a hemodynamically isolated segment of the rat common carotid artery results in virtually a total denudation of the endothelium but with only limited damage to the underlying subendothelial structures and the media (Figs 1 and 3 ). In accordance with these results, Fishman et a18 and Dryski et al9 have shown that 12 to 24 hours after injury, the endothelially denuded injured area is covered with a carpet of platelets. Starting at 2 days, the platelet carpet is progressively replaced from both ends by a new sheet of endothelium, which occurs by ingrowth from both ends of the denuded segment. This is consistent with our scanning electron microscopy results. Approximately 4 Thus, SPM-5185 may have protected this model of vascular injury by an antineutrophil action. We have no direct information on this mechanism of action from our present study, and we saw very few adherent leukocytes on the injured intimal surface.
Fifth, NO donors like SPM-5185 could protect against injury by virtue of the fact that NO quenches superoxide radicals,33 and SPM-5185 could reduce the effective local concentration of superoxide radicals. We tested this possibility by using recombinant hSOD, which works well in rats34 but did not protect in this model of vascular injury. However, it is likely that the hSOD could not penetrate the vascular wall, where the generation of superoxide radicals would most likely occur. Thus, we cannot eliminate the superoxide radical-scavenging activity of SPM-5185 as a primary mechanism of protection in this model of vascular injury. It is possible that quenching of oxygen-derived free radicals may contribute to the overall cytoprotective effect of NO in this model of intimal injury.
In summary, we have demonstrated a significant effect of accelerating recovery from intimal injury after a constant intravenous infusion of an NO donor, SPM-5185, in a rat carotid arterial injury model. The intimal thickening was reduced by 82% compared with treatment with an inactive NO donor. Basal NO release and vasodilator-stimulated NO release were significantly increased by the regenerated endothelial cells, as evidenced by a significant increase in the ability to respond to the NO synthase inhibitor L-NAME and to endothelium-dependent vasodilators (eg, ACh and A23187). The data in the present study suggest that NO may be another intervention for preventing or ameliorating the vasospasm and restenosis occurring after angioplasty by attenuating vascular smooth muscle growth and promoting the regeneration of endothelial cells. These findings are consistent with those of Garg and Hassid,12 who showed that S-nitroso-N-acetylpenacillamine, another NO donor, inhibited cultured rat vascular smooth muscle cell proliferation. Thus, endogenous NO may play an important role in preventing or attenuating neointimal formation, as suggested by Scott-Burden et al. 35 
